Renal cancer new treatments
Stanculeanu, Renal cancer new treatments.
Related Stories
Zob, A. Lazescu Institute of Oncology Bucharest, Romania Abstract Rezumat This paper describes the currently available drugs for the treatment of advanced kidney cancer.
These are represented by more molecules that activate on vascular endothelial receptor VEGFR : sunitinib, sorafenib, pazopanib, axitinib renal cancer new treatments VEGF inhibitors: bevacizumab.
Another category is that of mTOR inhibitors: temsirolimus and everolimus. In Romania the following substances are available: sunitinib, sorafenib, temsirolimus and bevacizumab.
In this context we present a typical case of metastatic clear cell renal cancer that received treatment with sunitinib with stationary disease 9 months and then after disease progression the patient received treatment with temsirolimus, the response being comparable with that obtained in trials published with this treatment. Keywords: drugs, kidney cancer treatment Lucrarea de față descrie medicamentele disponibile la ora ac tuală pentru tratamentul cancerului renal avansat.
Acestea sunt reprezentate de mai multe molecule cu activitate asupra receptorilor vasculari endoteliali VEGFR : sunitinib, sorafenib, pazopanib, sarcoma cancer breast și a inhibitorilor de VEGF: bevacizumab. O altă categorie este aceea a inhibitorilor de mTOR: temsirolimus și everolimus.
Credit: Dr. Rui Kuai and Dr. Wenmin Yuan In the wrestling match with cancer, chemoimmunotherapy is the new strong arm, renal cancer new treatments it is building muscle with a nanodisc disguised as "good cholesterol. The nanodisc is made of a synthetic version of high density lipoprotein HDLalso known as " good cholesterol.
În România sunt disponibile următoarele substanțe: sunitinib, sorafenib, temsirolimus și bevacizumab. În acest context prezentăm un caz tipic de cancer renal cu celule clare metastatice care a beneficiat de tratament cu sunitinib renal cancer new treatments boală staționară 9 luni și ulterior după evoluția bolii, pacientul a beneficiat de tratament cu temsirolimus, răspunsul fiind comparabil cu cel obținut în trialurile publicate cu acest tratament.
Cuvinte-cheie: medicamente, tratament cancer renal Introduction Renal cancer represents 4. Annually, in the world are diagnosednew cases of renal cancer and there aredeaths.
Median age at diagnostic is 60 years.
Stage IV kidney cancer patient sees success with RADVAX trial
In Romania renal cancer is situated on the 12 th place of all cancers with an estimated incidence of 7. Since then, the number of new molecules renal cancer new treatments in renal cancer treatment raised to 7.
This fact is observed in survival renal cancer new treatments with an increased median survival from First therapeutic classes used as antiangiogenic treatment were: 1. MTor Inhibitors: a. Figure 1.